Home » Topics » BioWorld Science

BioWorld Science
RSS

New FPP-based inhibitor of protein farnesyltransferase discovered at Banyu

Dec. 15, 1997

E-4010: highly potent and selective PDE V inhibitor from Eisai

Dec. 15, 1997

Eisai develops novel retinoids as highly potent and selective RXR agonists

Dec. 15, 1997

Discovery of novel, orally active ACAT inhibitor, FR-186054, reported by Fujisawa

Dec. 15, 1997

Novel hypoglycemic thiazolidinedione derivative presented by Kyorin

Dec. 15, 1997

Company Profile: CombiChem

Dec. 15, 1997

FDA approves URSO for PBC

Dec. 12, 1997

Genzyme Transgenics' idiotypic vaccines show promise in clinical trials

Dec. 12, 1997

First FDA approval for humanized MAb: Zenapax for renal transplant patients

Dec. 12, 1997

Cel-Sci expands Multikine trial

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...